Target intelligence / Profile preview

Gastrointestinal microbiota composition modulation (None established; sometimes referred to as "gut microbiota modulation" in the literature[1].)

Target
None established; sometimes referred to as "gut microbiota modulation" in the literature[1].
Molecular classification
Other (not a molecule/protein/receptor/enzyme/transporter), Represents an ecological/functional process involving many species and pathways rather than one defined molecular entity[1][2]
01

Overview

"Gastrointestinal microbiota composition modulation" refers broadly to any intentional alteration—through diet, supplementation with live microorganisms (“probiotics”), prebiotic compounds that feed beneficial bacteria (“prebiotics”), antibiotics that suppress certain populations, or even fecal transplants—of the complex ecosystem comprising trillions of microorganisms within the human digestive tract. The goal is typically restoration or maintenance of eubiosis—a balanced state associated with health—or correction/prevention/treatment of disease states linked with dysbiosis. This field recognizes that shifts in microbial populations can profoundly affect host physiology including metabolism, immune function, inflammation control and even neurological outcomes via metabolite production and signaling pathways between microbes and host tissues. Because it describes an approach encompassing numerous targets/mechanisms/species/metabolites—and not one discrete druggable entity—it should be classified under “Other” rather than traditional molecular targets like receptors or enzymes.[1][2][3][4]

Other names
Gut microbiota modulationModulation of gut microbial compositionMicrobiome manipulationAlteration of gut flora
02

Mechanism of action

Not applicable for this entry as it is not one mechanism but encompasses multiple strategies: Introduction/supplementation with beneficial microbes ("probiotic effect"); Promotion of beneficial microbe growth via substrates ("prebiotic effect"); Suppression/elimination of pathogenic/harmful microbes via antibiotics or bacteriophages; Restoration/replacement through fecal transplant. These mechanisms ultimately aim to shift the overall community structure toward health-associated profiles.

03

Biological functions

Regulation of nutrient metabolismImmune system development and modulationMaintenance of intestinal barrier integrityInflammatory response regulationSynthesis of vitamins and bioactive metabolites (e.g., short-chain fatty acids)[4]
04

Disease associations

Infection (e.g., Clostridioides difficile infection)Inflammation (e.g., inflammatory bowel disease)Metabolic syndrome/obesity/diabetes[8]Neurological disorders (via gut-brain axis)[2]Cancer risk/modulation
05

Safety considerations

Risk of unintended dysbiosis leading to adverse effects.Potential transfer/introduction of pathogens during fecal transplantation.Individual variability in response—personalized approaches often required due to differences in baseline microbial communities.Long-term safety data lacking for many interventions.
06

Interacting drugs

Probiotics (Lactobacillus spp., Bifidobacterium spp.)

4 more in the full profile.

07

Biomarkers

No direct biomarkers for “modulation” itself; however, relative abundance/diversity indices from metagenomic sequencing can serve as biomarkers for monitoring efficacy.Levels of specific metabolites such as short-chain fatty acids, bile acids, tryptophan derivatives may be used to assess functional changes in response to interventions[4].

Beyond the preview

Go deeper on Gastrointestinal microbiota composition modulation (None established; sometimes referred to as "gut microbiota modulation" in the literature[1].).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal microbiota composition modulation (None established; sometimes referred to as "gut microbiota modulation" in the literature[1].).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call